Philadelphia is home to the nation’s first hospital, the Liberty Bell, and now NTM Info & Research’s 2020 Conference!
We hope to see you at the 2020 NTM & Bronchiectasis Physician/Patient Conference, the largest patient-oriented NTM/Bronchiectasis meeting in the world. The full day CME session on May 15, 2020 at Renaissance Philadelphia Airport Hotel, Philadelphia, Pennsylvania, United States of America. It features an internationally renowned faculty in the fields of nontuberculous mycobacterial disease and bronchiectasis. This Conference has been approved for a maximum of 6 CME Credits.
The patient half-day session will be held on May 14, 2020.
The first day will consist of patient-centric sessions designed to help them tackle the profound challenges they face living with their disease. At the conclusion of this session, there will be a dinner for patients to interact with one another in a less formal setting. As one attendee of the 2019 conference noted on the evaluation, a patient-focused session is “very helpful and educational for patients managing the disease.” A caregiver noted that the conference gave him a “better understanding of my role as a caregiver and support for bronchiectasis.”
The second day, which will be CME-certified by Postgraduate Institute for Medicine, will consist of clinical sessions geared towards healthcare providers, though registration will be open to all. The conference will also feature an exhibit hall in a separate location from the lecture hall.
As new therapies emerge on the horizon, educating the physician and allied healthcare provider communities on symptoms, diagnosis and management of NTM and bronchiectasis becomes even more essential. Managing this complex disease requires addressing both the infection – NTM – and the underlying lung disease itself, which very often manifests as bronchiectasis. It requires a support team with multiple specialists’ expertise in order to provide well-rounded care for the patient.
The NTM & Bronchiectasis conference addresses gaps in these areas of knowledge, properly demonstrating this as a “dual disease state” and providing a comprehensive overview of the steps necessary to properly help the patient, from diagnostics to managing the myriad side effects of treatments. As one physician attendee of the 2019 conference noted: “I felt that every single lecture provided me with new ideas for diagnosis or treatment of bronchiectasis or NTM.”
Upon completion of this conference, participants should be able to:
• Describe the recommended treatment guidelines for the most common NTM lung infections
• Describe some reasons that a minority of prescribed regimens in the US follow the recommended ATS/IDSA guidelines
|Contact No. :||3056676461
|Registration Type||Last Date||Price|
|Healthcare and Industry Professional: Clinical Sessions (Friday Only) Fee||14 May,2020||USD 50.00|
|Healthcare and Industry Professional: Patient and Clinical Sessions (Both Days) Fee||13 May,2020||USD 75.00|
|Patient: NTM Conference May 14th or 15th, 2020 Fee||13 May,2020||USD 25.00|
|Patient: NTM Conference May 14th and 15th, 2020 Fee||13 May,2020||USD 50.00|